A detailed history of Shikiar Asset Management Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Shikiar Asset Management Inc holds 787 shares of REGN stock, worth $552,355. This represents 0.23% of its overall portfolio holdings.

Number of Shares
787
Previous 799 1.5%
Holding current value
$552,355
Previous $840,000 1.55%
% of portfolio
0.23%
Previous 0.23%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$1024.09 - $1201.76 $12,289 - $14,421
-12 Reduced 1.5%
787 $827,000
Q2 2024

Jul 16, 2024

SELL
$883.2 - $1071.19 $44,160 - $53,559
-50 Reduced 5.89%
799 $840,000
Q1 2024

Apr 22, 2024

BUY
$902.69 - $993.35 $9,929 - $10,926
11 Added 1.31%
849 $817,000
Q4 2023

Feb 01, 2024

SELL
$775.18 - $881.7 $829,442 - $943,419
-1,070 Reduced 56.08%
838 $736,000
Q3 2023

Oct 31, 2023

SELL
$692.45 - $844.37 $247,897 - $302,284
-358 Reduced 15.8%
1,908 $1.57 Million
Q2 2023

Jul 20, 2023

SELL
$700.03 - $830.35 $39,901 - $47,329
-57 Reduced 2.45%
2,266 $1.63 Million
Q1 2023

Apr 20, 2023

SELL
$680.49 - $826.97 $40,148 - $48,791
-59 Reduced 2.48%
2,323 $1.91 Million
Q3 2022

Oct 25, 2022

SELL
$573.97 - $724.32 $335,198 - $423,002
-584 Reduced 19.69%
2,382 $1.64 Million
Q2 2022

Jul 15, 2022

SELL
$548.35 - $738.84 $358,072 - $482,462
-653 Reduced 18.04%
2,966 $1.75 Million
Q1 2022

Apr 13, 2022

BUY
$595.12 - $698.43 $20,829 - $24,445
35 Added 0.98%
3,619 $2.53 Million
Q4 2021

Jan 21, 2022

SELL
$543.48 - $670.97 $186,413 - $230,142
-343 Reduced 8.73%
3,584 $2.26 Million
Q3 2021

Oct 29, 2021

BUY
$574.03 - $680.96 $1.1 Million - $1.31 Million
1,917 Added 95.37%
3,927 $2.38 Million
Q2 2021

Jul 16, 2021

BUY
$472.8 - $558.54 $185,810 - $219,506
393 Added 24.3%
2,010 $1.12 Million
Q1 2021

May 05, 2021

SELL
$446.73 - $548.2 $1.63 Million - $2 Million
-3,644 Reduced 69.26%
1,617 $765,000
Q4 2020

Feb 03, 2021

SELL
$478.3 - $607.98 $3.35 Million - $4.26 Million
-7,009 Reduced 57.12%
5,261 $2.54 Million
Q3 2020

Oct 28, 2020

BUY
$544.75 - $658.21 $1.79 Million - $2.17 Million
3,295 Added 36.71%
12,270 $6.87 Million
Q2 2020

Aug 20, 2020

BUY
$493.32 - $643.92 $4.43 Million - $5.78 Million
8,975 New
8,975 $5.6 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Shikiar Asset Management Inc Portfolio

Follow Shikiar Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shikiar Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Shikiar Asset Management Inc with notifications on news.